Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

February 29, 2012

Conditions
Diabetic Macular EdemaMacular Edema, CystoidVision DisordersClinically Significant Macular Edema
Interventions
DRUG

long acting intravitreal dexamethasone implant

Intravitreal ozurdex was given in diabetic patients with clinically significant macular edema and they were followed up for change in central macular thickness and visual acuity over a period of 6 months

Trial Locations (1)

160012

Pooja Bansal, Chandigarh

All Listed Sponsors
lead

Post Graduate Institute of Medical Education and Research, Chandigarh

OTHER

NCT01698749 - Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema | Biotech Hunter | Biotech Hunter